No results for ‘’
Thyrocare Technologies Ltd
₹540.55
(1.15%)
Wed, 24 Jun 2026, 06:44 pm
Health Services
Medical/Nursing Services
24.5KThyrocare Technologies Enterprise Value (EV)
| Particulars | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 89.69 | 34.71 | 33.34 | 29.67 | 42.26 | 23.27 | 35.32 | 44.39 | 39.48 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 0 | 9.40 | 7.29 | 6.44 | 7.14 | 11.17 | 7.77 | 4.26 | 5.95 | 6.59 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 0 | 12.62 | 9.08 | 7.04 | 6.04 | 9.67 | 6.96 | 4.32 | 5.49 | 5.26 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 40.62 | 29.17 | 27.80 | 15.57 | 41.13 | 36.68 | 17.44 | 19.11 | 18.73 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 0 | 3722Cr | 3125Cr | 2757Cr | 2555Cr | 4670Cr | 3981Cr | 2151Cr | 3008Cr | 3446Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 31.56 | 21.10 | 17.76 | 14.38 | 26.55 | 16.71 | 17.17 | 21.05 | 17.80 |
| Debt to equity ratio | 0.37 | 0.24 | 0.16 | 0.12 | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0.02 | 0.04 | 0.04 | 0.08 | 0.05 |
| Return on equity % | 0 | 41.11 | 43.28 | 25.20 | 18.57 | 16.18 | 11.08 | 21.95 | 19.39 | 22.05 | 28.50 | 36.93 | 12.16 | 13.34 | 17.05 |
Thyrocare Technologies Ltd Enterprise Value
The Thyrocare Technologies Ltd Enterprise Value is a key financial metric used by investors to evaluate Thyrocare Technologies Ltd's valuation, profitability, and overall financial performance. Tracking the Thyrocare Technologies Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Thyrocare Technologies Ltd (NSE: THYROCARE, BSE: 539871) is currently trading at ₹540.55, with a market capitalization of ₹8501.82Cr. As a leading company in the Health services sector and Medical/Nursing services industry, monitoring the Thyrocare Technologies Ltd Enterprise Value is essential for fundamental analysis.
Thyrocare Technologies Ltd Enterprise Value Current Value
The current Thyrocare Technologies Ltd Enterprise Value stands at 3446Cr.
The latest Thyrocare Technologies Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Thyrocare Technologies Ltd Enterprise Value Historical Trend
The Thyrocare Technologies Ltd Enterprise Value has shown the following historical trend:
- 2024: 3446Cr
- 2023: 3008Cr
- 2022: 2151Cr
- 2021: 3981Cr
- 2020: 4670Cr
The recent rise in Thyrocare Technologies Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Thyrocare Technologies Ltd Enterprise Value Indicates for Investors
The Thyrocare Technologies Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Thyrocare Technologies Ltd.
Thyrocare Technologies Ltd Enterprise Value Analysis Summary
The Thyrocare Technologies Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Thyrocare Technologies Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Thyrocare Technologies Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.